Koers Great Novel Therapeutics Biotech & Medicals
Aandelen
7427
TW0007427007
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
55 TWD | 0,00% | -3,51% | -17,66% |
Omzet 2022 | 540K 16,73K 15,53K | Omzet 2023 | 4,85 mln. 150K 139K | Marktkapitalisatie | 2,56 mld. 79,39 mln. 73,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -55 mln. -1,7 mln. -1,58 mln. | Nettowinst (verlies) 2023 | -61 mln. -1,89 mln. -1,75 mln. | EV/omzet 2022 | 2.918 x |
Nettoliquiditeiten 2022 | 248 mln. 7,67 mln. 7,12 mln. | Nettoliquiditeiten 2023 | 463 mln. 14,34 mln. 13,31 mln. | EV/omzet 2023 | 433 x |
K/w-verhouding 2022 |
-27,2
x | K/w-verhouding 2023 |
-39,3
x | Werknemers | 12 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
1 week | -3,51% | ||
Lopende maand | -1,08% | ||
1 maand | -12,97% | ||
3 maanden | +11,68% | ||
6 maanden | -21,09% | ||
Lopend jaar | -17,66% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chia Nan Chen
CEO | Chief Executive Officer | - | 03-04-13 |
Ying Chang Huang
DFI | Director of Finance/CFO | - | 04-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hung Jen Wu
BRD | Director/Board Member | - | 26-09-13 |
Chung Yang Huang
BRD | Director/Board Member | - | 02-06-17 |
Tien Tzu Tseng
BRD | Director/Board Member | - | 14-05-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-05-24 | 55 | 0,00% | 41 114 |
02-05-24 | 55 | -1,08% | 48 567 |
30-04-24 | 55,6 | +1,09% | 65 549 |
29-04-24 | 55 | -3,51% | 100 293 |
26-04-24 | 57 | +1,24% | 179 803 |
slotkoers Taipei Exchange, 03 mei 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-17,66% | 65,56 mln. | |
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |